Literature DB >> 8550224

Persistence of serum and salivary antibody responses after oral immunization with a bacterial protein antigen genetically linked to the A2/B subunits of cholera toxin.

G Hajishengallis1, S M Michalek, M W Russell.   

Abstract

Primary oral immunization of mice with a bacterial protein antigen genetically coupled to the A2 and B subunits of cholera toxin induced specific secretory immunoglobulin A and serum immunoglobulin G antibodies that persisted at substantial levels for at least 11 months. A subsequent single booster immunization did not further enhance the antibody responses. Long-term antibody persistence may be especially important in infections caused by common pathogens for which continuous immunity would be advantageous.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8550224      PMCID: PMC173818          DOI: 10.1128/iai.64.2.665-667.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  15 in total

Review 1.  Immunization against dental caries.

Authors:  M W Russell
Journal:  Curr Opin Dent       Date:  1992-09

Review 2.  Development and outlook for a caries vaccine.

Authors:  S M Michalek; N K Childers
Journal:  Crit Rev Oral Biol Med       Date:  1990

Review 3.  Mucosal immunity and vaccination.

Authors:  J Holmgren
Journal:  FEMS Microbiol Immunol       Date:  1991-12

4.  Distribution, persistence, and recall of serum and salivary antibody responses to peroral immunization with protein antigen I/II of Streptococcus mutans coupled to the cholera toxin B subunit.

Authors:  M W Russell; H Y Wu
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

5.  Cholera toxin adjuvant promotes long-term immunological memory in the gut mucosa to unrelated immunogens after oral immunization.

Authors:  M Vajdy; N Y Lycke
Journal:  Immunology       Date:  1992-03       Impact factor: 7.397

6.  B-cell memory is short-lived in the absence of antigen.

Authors:  D Gray; H Skarvall
Journal:  Nature       Date:  1988-11-03       Impact factor: 49.962

7.  Determinants of the localization, magnitude, and duration of a specific mucosal IgA plasma cell response in enterically immunized rats.

Authors:  N F Pierce; W C Cray
Journal:  J Immunol       Date:  1982-03       Impact factor: 5.422

Review 8.  The maintenance and regulation of the humoral immune response: persisting antigen and the role of follicular antigen-binding dendritic cells as accessory cells.

Authors:  J G Tew; R P Phipps; T E Mandel
Journal:  Immunol Rev       Date:  1980       Impact factor: 12.988

9.  Inhibition of Streptococcus mutans adherence to saliva-coated hydroxyapatite by human secretory immunoglobulin A (S-IgA) antibodies to cell surface protein antigen I/II: reversal by IgA1 protease cleavage.

Authors:  G Hajishengallis; E Nikolova; M W Russell
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

10.  Intestinal immune responses in humans. Oral cholera vaccination induces strong intestinal antibody responses and interferon-gamma production and evokes local immunological memory.

Authors:  M Quiding; I Nordström; A Kilander; G Andersson; L A Hanson; J Holmgren; C Czerkinsky
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

View more
  16 in total

1.  Heteropentameric cholera toxin B subunit chimeric molecules genetically fused to a vaccine antigen induce systemic and mucosal immune responses: a potential new strategy to target recombinant vaccine antigens to mucosal immune systems.

Authors:  Tetsuya Harakuni; Hideki Sugawa; Ai Komesu; Masayuki Tadano; Takeshi Arakawa
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

2.  Oral immunization with the saliva-binding region of Streptococcus mutans AgI/II genetically coupled to the cholera toxin B subunit elicits T-helper-cell responses in gut-associated lymphoid tissues.

Authors:  N Toida; G Hajishengallis; H Y Wu; M W Russell
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

3.  Mucosal immunization with a Staphylococcus aureus IsdA-cholera toxin A2/B chimera induces antigen-specific Th2-type responses in mice.

Authors:  Britni M Arlian; Juliette K Tinker
Journal:  Clin Vaccine Immunol       Date:  2011-07-06

4.  Long-term immunological memory induced by recombinant oral Salmonella vaccine vectors.

Authors:  J J Kohler; L Pathangey; A Hasona; A Progulske-Fox; T A Brown
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

5.  Mucosal immunogenicity of a holotoxin-like molecule containing the serine-rich Entamoeba histolytica protein (SREHP) fused to the A2 domain of cholera toxin.

Authors:  F Sultan; L L Jin; M G Jobling; R K Holmes; S L Stanley
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

6.  Monoclonal antibody-mediated modulation of the humoral immune response against mucosally applied Streptococcus mutans.

Authors:  L J Brady; M L van Tilburg; C E Alford; W P McArthur
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

7.  Limited local and systemic antibody responses to Neisseria gonorrhoeae during uncomplicated genital infections.

Authors:  S R Hedges; M S Mayo; J Mestecky; E W Hook; M W Russell
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

8.  Endochitinase is transported to the extracellular milieu by the eps-encoded general secretory pathway of Vibrio cholerae.

Authors:  T D Connell; D J Metzger; J Lynch; J P Folster
Journal:  J Bacteriol       Date:  1998-11       Impact factor: 3.490

9.  Identification and characterization of intestinal antigen-presenting cells involved in uptake and processing of a nontoxic recombinant chimeric mucosal immunogen based on cholera toxin using imaging flow cytometry.

Authors:  Weiwei Zhao; Hans Minderman; Michael W Russell
Journal:  Clin Vaccine Immunol       Date:  2013-11-06

10.  Nontypeable Haemophilus influenzae: pathogenesis and prevention.

Authors:  A R Foxwell; J M Kyd; A W Cripps
Journal:  Microbiol Mol Biol Rev       Date:  1998-06       Impact factor: 11.056

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.